Syndication Partners
Strong syndication partners bring additional expertise and resources to support partner company management and to ensure that our partner companies are adequately financed to exit or profitability. Safeguard’s branded history and stability enable it to generate better deal flow, source accomplished entrepreneurs, attract top syndication partners and gain access to the management and boards of Fortune 500 companies for strategic purposes. Safeguard works to leverage its branded footprint and its out-bound deal sourcing capabilities throughout the Mid-Atlantic and Southeast regions of the U.S. However, Safeguard also enjoys robust in-bound deal sourcing capabilities from Investment bankers, syndication partners and advisory board members who provide candidate companies throughout the U.S. and Eastern Canada.
Safeguard's alliance and syndication partners for our partner companies include:
- Alliance Technology Ventures
- AllianceBernstein Ventures
- Alta Partners
- Atlas Ventures
- Bain Capital / Brookside Partners
- Battelle Ventures
- Bay City Capital / Birchmere Partners
- BioAdvance
- Canaan Partners
- Carlyle
- Channel Medical Partners
- CDIB BioScience Ventures
- Constellation Ventures II
- Deerfield Partners
- Edison Venture Fund
- Founders Equity
- Healthcap Partners
- HIG Ventures
- J&J Development Corporation
- L Capital Partners
- Lilly Ventires
- New Venture Partners
- Oak Investment Partners
- One Equity Partners
- Orbimed
- Oxford Bioscience Partners
- Pfizer Ventures
- QED Investors
- Quaker BioVentures
- Red Abbey Venture Partners
- RK Ventures
- SCP Vitalife Partners
- SR One
- SV Life Sciences
- Thomas McNerny Partners
- TPG Biotech
- Westbury Equity Partners
- Wheatley Partners
